Header graphic for print
MoFo Tech A blog dedicated to information, trend spotting & analysis for science- & tech-based companies

Tag Archives: pharma

For the Common Good

For-profits and nonprofits in life sciences team up Nonprofit groups are actively supporting research to solve tough medical challenges. Life sciences and pharma companies are eager to accelerate product development. Now, new business models are emerging to leverage the strengths of each. One example: the licensing partnership between Medicines360, a San Francisco-based nonprofit pharma company… Continue Reading

Sharing an Umbrella

Big Pharma and academia cement big deals in the quest for bigger prizes With the patents of many highly profitable blockbuster drugs expiring over the course of a few years, the search is on for new drugs to fill large pharmaceutical companies’ shrinking product portfolios. For years, Big Pharma has turned to smaller biotech companies… Continue Reading

The End of “Pay For Delay”?

More brand-name drug companies have been paying their competitors to delay their efforts to bring generic versions of blockbuster pharmaceuticals to market. The Federal Trade Commission estimates there were 28 “reverse payment” agreements in 2011—twice the number in 2007—involving 25 different branded pharmaceuticals with annual U.S. sales of more than $9 billion. A string of… Continue Reading

China: Innovation for Sale

The Chinese government has been encouraging overseas pharmaceutical companies to outsource R&D to Chinese firms—part of an effort to move into more high-value work.  The draw: a growing, cost-effective bioscience talent pool made up of both local graduates and “sea turtles” who went to U.S. universities and returned, according to Morrison & Foerster partner Gordon… Continue Reading